Octreotide
- 25 January 1996
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 334 (4) , 246-254
- https://doi.org/10.1056/nejm199601253340408
Abstract
A peptide inhibiting the release of growth hormone was originally detected accidentally during studies of the distribution of growth hormone–releasing factor in the hypothalamus of rats.1 This peptide, called somatostatin, proved to be a cyclic peptide consisting of 14 amino acids.2 Subsequent work has considerably expanded this initially simple concept of somatostatin as a peptide whose main function is the regulation of growth hormone secretion.3 Today, somatostatin is best regarded as a phylogenetically ancient, multigene family of peptides with two important bioactive products: somatostatin-14 and somatostatin-28, the latter a congener of somatostatin-14 extended at the N-terminal.3,4 Like other peptide . . .Keywords
This publication has 69 references indexed in Scilit:
- Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineageJournal of Clinical Endocrinology & Metabolism, 1994
- Phospholipase C activation and Ca2+ mobilization by cloned human somatostatin receptor subtypes 1–5, in transfected COS‐7 cellsFEBS Letters, 1994
- All Five Cloned Human Somatostatin Receptors (hSSTR1-5) Are Functionally Coupled to Adenylyl CyclaseBiochemical and Biophysical Research Communications, 1994
- Distribution and second messenger coupling of four somatostatin receptor subtypes expressed in brainFEBS Letters, 1993
- Clinically nonfunctioning pituitary adenoma and octreotide response to long term high dose treatment, and studies in vitroJournal of Clinical Endocrinology & Metabolism, 1992
- Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cellsEndocrinology, 1992
- Treatment of the Malignant Carcinoid SyndromeNew England Journal of Medicine, 1986
- Long-Term Treatment of Acromegaly with the Somatostatin Analogue SMS 201–995New England Journal of Medicine, 1985
- SomatostatinNew England Journal of Medicine, 1983
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982